Article

Thrive Genetics and Varyence Partner on a Personalized Genomics Solution for Addiction Risk Management

 

  1. Philadelphia, PA – September 4, 2024 – Thrive Genetics, a leader in precision medicine for addiction, and Varyence, a company focused on investing into and building SaaS startups, today announced a partnership to help the healthcare industry with addiction risk management. 

This collaboration will leverage Thrive Genetics’ platform, Thrive CARES (Comprehensive Addiction Risk Evaluation System), to integrate personalized genomic and environmental risk assessments.  

Varyence is committed to helping individuals improve their lives through innovative healthcare technology and is excited to invest into Thrive Genetics to help bring this precision medicine technology to market to fight addiction risk.  

“Thrive Genetics is thrilled to partner with Varyence to empower individuals with a deeper understanding of their addiction risk,” said James J Piacentino, CEO of Thrive Genetics. “By combining our industry-leading Thrive CARES platform with Varyence’s innovative technology, we can provide a more comprehensive and personalized approach to addiction prevention and management.”

Thrive CARES: Personalized Addiction Risk Assessment 

Thrive CARES is a powerful tool that utilizes both genetics and behavioral data to create a personalized risk assessment for addiction. This unique approach goes beyond traditional methods by: 

  1. Analyzing millions of genetic markers

    Analyzing millions of genetic markers to identify an individual’s genetic predisposition to addiction. 

  2. Incorporating data from over 50,000 individuals 

    Incorporating data from over 50,000 individuals tracked over time to understand the behavioral and environmental factors that contribute to addiction risk. 

  3. Providing actionable insights 

    Providing actionable insights to help individuals make informed decisions about their health.

 

The Varyence and Thrive Genetics Partnership: A Powerful Force for Change

•Earlier intervention: 
By identifying individuals at higher risk of addiction, earlier intervention and prevention strategies can be implemented. 

•More effective treatment: 
Personalized insights can help tailor treatment plans to the specific needs of each individual. 

•Reduced healthcare costs: 
Early intervention and prevention can significantly reduce the long-term costs associated with addiction. 

About Thrive Genetics

Thrive Genetics is a pioneering company dedicated to using genomics and data science to revolutionize how pre-addiction signaling and general addiction is managed in society. The company’s flagship product, Thrive CARES, is a comprehensive addiction risk evaluation system that provides individuals with personalized insights into their risk for addiction including data management support for institutions and corporations. Thrive Genetics is committed to developing innovative tools that empower individuals to take control of their health.   Founded in Philadelphia, PA.

About Varyence 

Varyence is a New York based global technology company that helps launch and scale innovative startups. Varyence has over 100 employees and has been in business for over 10 years. Varyence has been helping launch and scale healthcare startups and has specialized expertise working in precision medicine since 2019. Varyence also maintains a private equity fund called Get Startup Funding which invests cash, development services, and business advisory services into startups to help them launch and scale.

Use Varyence to build your startup software

We provide top Ukraine development teams and technical leadership for non-technical founders of early-stage SaaS startups to build their dreams. 
Schedule Call
Varyence Thrive Genetics and Varyence Partner on a Personalized Genomics Solution for Addiction Risk Management getintouch